NBP — NovaBridge Biosciences Share News
0.000.00%
Last trade - 00:00- $158.92m
- -$31.93m
Brief: Visara Expands Ophthalmology Pipeline With Exclusive License For Investigational Nerve Growth Factor Therapy For Neurotrophic Keratitis
Brief: Wuhan Hiteck Biological Pharma Grants Visara Exclusive Rights To HT006.2.2 Outside Greater China
Brief: Novabridge Biosciences Announces Expanded Givastomig Safety And Efficacy Data
NovaBridge Biosciences expected to post a loss of 13 cents a share - Earnings Preview
NovaBridge Biosciences expected to post a loss of 13 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-RBB Bancorp, Roblox, Open Lending
U.S. STOCKS ON THE MOVE-Amkor Technology, Dynatrace, Corvex
U.S. STOCKS ON THE MOVE-Qualcomm, Robinhood
U.S. STOCKS ON THE MOVE-Qualcomm, Robinhood, Mobileye
NovaBridge rises as stomach cancer drug combo gets FDA fast-track status
Brief: NovaBridge Announces Productive FDA Type B Meeting On Potential Accelerated Approval Pathway For Givastomig In Gastric Cancer
U.S. STOCKS ON THE MOVE-Hewlett Packard Enterprise, Dianthus, 3D Systems
U.S. STOCKS ON THE MOVE-Biotechs, Agilent, Dow
U.S. STOCKS ON THE MOVE-Hims & Hers, Live Nation, NovaBridge
NovaBridge gains as eye disease drug shows promise in mid‑stage trial
Brief: Novabridge Appoints Biotech Leader, Emmett T. Cunningham, Jr, MD, Phd, MPH, As Vice Chairman Of The Board
U.S. STOCKS ON THE MOVE-United Airlines Holdings, Energy companies, Tesla
U.S. STOCKS ON THE MOVE-Shake Shack, Arrowhead Pharmaceuticals, Lockheed Martin
U.S. STOCKS ON THE MOVE-Alkermes, Ball Corp, NovaBridge